The Importance of Accessible Alternatives in Harm Reduction

Tobacco harm reduction involves minimizing the negative health impacts caused by smoking, while recognizing that some people cannot or do not want to quit using nicotine. One way to achieve this goal is to help consumers find something that works for them but isn't a cigarette. However, this approach can only be effective if:

• Consumers have access to products they want to use instead of cigarettes, and
• They were confident that these products are, in fact, of reduced risk compared to cigarettes.

Smokers Need Products That Work for Them – Flavor Bans Don't Work

Smokers need products they truly enjoy and want to use, and that includes alternatives to cigarettes. An important aspect of these alternative products, which differentiates them from smoking, is the availability of a wide variety of flavors. Appealing flavors are a key factor in facilitating the transition of smokers to less harmful options, such as vaporizers or nicotine pouches.

However, some regulators have adopted the view that because flavors are banned in cigarettes, they should also be banned in alternative products. The assumption is that removing flavors will reduce smoking and vaping. However, practical experience shows that this is not the case.

A study conducted in seven US states that introduced bans on flavored vapes, for example, found that while sales of flavored liquids fell (because of the ban), there was a side effect: for every 0.7 mL of liquid that wasn't sold, 12 additional cigarettes were purchased. Essentially, the effect of the flavor ban was to cause vape users to revert to cigarettes. This result is concerning, as poorly conceived policies can increase smoking rates instead of reducing them, as also discussed in a Washington Times editorial on the impacts of these policies in the US.

Sweden, Snus and Cardiovascular Disease

Sweden is poised to become the first country to achieve "smoke-free" status, largely due to easy access to a reduced-risk, smoke-free product—snus. Snus, a traditional oral tobacco product, has been one of the biggest contributing factors to the drastic reduction in cigarette use in the country.

There are many studies on the benefits of switching to snus, but until recently there were doubts about the effect of snus on blood vessels and the cardiovascular system. A study published in the journal Nicotine & Tobacco Research , however, showed that the risk of cardiovascular disease among users of smokeless tobacco products (ST), such as Swedish snus, is the same as that of those who have never smoked. The study, which involved 4,347 adults, revealed that this was true, despite ST users being exposed to more nicotine than smokers. These findings support the idea that the increased risk of cardiovascular disease among cigarette smokers is mainly caused by the chemicals present in tobacco smoke, and not by nicotine itself.

Misinformation discourages change.

Studies like this are important, and consumers need to be aware of scientific data relevant to the product they choose. This is crucial because, even if consumers find a product they want to use, they need to be confident that it is safer than cigarettes.

Unfortunately, misinformation and misinterpretation are common. Research repeatedly shows that, despite numerous pieces of evidence to the contrary, many people still believe that vaping is as harmful, or more harmful, than smoking. This misconception has proven to be a significant barrier to behavioral change—there are far more smokers than vaping users.

It's important to clarify that vaping products don't burn tobacco, so there's no smoke. Consequently, vaporizer users aren't inhaling the many toxic chemicals present in smoke, known to cause tobacco-related illnesses.

Like vaporizers, nicotine pouches contain no tobacco, are not burned, and do not expose consumers to the toxins of smoke. This difference is crucial to understanding the harm reduction potential these products offer.

Encouraging Smokers to Quit

The mistaken belief that alternative products, such as vaporizers or nicotine pouches, are equally or more harmful than smoking, reduces the incentive for smokers to switch to them. Not all tobacco and nicotine products are equally harmful, and it is crucial that consumers are aware of this.

However, consumers are not the only ones who are confused. Healthcare professionals are often misinformed as well. As the evidence base grows for products such as vaporizers and other devices, both in terms of safety and effectiveness for harm reduction, physicians' understanding in the context of harm reduction must keep pace with the development of emerging scientific evidence.

Ensuring that consumers and those who guide them have the correct information will help guarantee that they can make informed decisions about what is best for them and their health.

Conclusion

Affordable and reduced-risk alternatives are a vital component of tobacco harm reduction strategies. Regulations that limit these options, such as flavor bans, can have the opposite effect to that desired, causing smokers to return to cigarette use. Snus in Sweden and the growing popularity of nicotine pouches in other markets offer examples of how reduced-risk products can help reduce the number of smokers and improve public health.

It is essential that consumers are well-informed about the products they are using and, especially, about the benefits that alternatives such as vaporizers and nicotine pouches can offer in terms of reducing health risks. Ongoing education, both for the public and for healthcare professionals, will be a fundamental tool to promote behavioral change and encourage more smokers to opt for less harmful alternatives.

With quality products, clear information, and easy access, we can continue to advance on the path to harm reduction and ultimately create a healthier future for all.